Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleOriginal Article

The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor

Tetyana Milojević, Veronika Reiterer, Eduard Stefan, Vladimir M. Korkhov, Mario M. Dorostkar, Eszter Ducza, Egon Ogris, Stefan Boehm, Michael Freissmuth and Christian Nanoff
Molecular Pharmacology April 2006, 69 (4) 1083-1094; DOI: https://doi.org/10.1124/mol.105.015818
Tetyana Milojević
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronika Reiterer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduard Stefan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir M. Korkhov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario M. Dorostkar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eszter Ducza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Egon Ogris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Boehm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Freissmuth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Nanoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 69 no. 4 1083-1094
DOI 
https://doi.org/10.1124/mol.105.015818
PubMed 
16339847

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 16, 2005
  • Accepted December 8, 2005
  • Published online March 21, 2006.

Article Versions

  • Earlier version (December 9, 2005 - 09:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Tetyana Milojević,
  2. Veronika Reiterer,
  3. Eduard Stefan,
  4. Vladimir M. Korkhov,
  5. Mario M. Dorostkar,
  6. Eszter Ducza,
  7. Egon Ogris,
  8. Stefan Boehm,
  9. Michael Freissmuth and
  10. Christian Nanoff
  1. Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology (T.M., V.R., E.S., V.M.K., M.M.D., E.D., S.B., M.F., C.N.) and Department of Medical Biochemistry at the Vienna Biocenter (E.O.), Medical University of Vienna, Vienna, Austria
  1. Address correspondence to:
    Dr. Michael Freissmuth, Institute of Pharmacology, Medical University of Vienna, Währinger Str. 13a, A-1090 Vienna, Austria. E-mail: michael.freissmuth{at}meduniwien.ac.at
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2005 to April 2021

AbstractFullPdf
Dec 2005180168
Jan 2006140180
Feb 200612092
Mar 20068740116
Apr 2006326386
May 2006204144
Jun 2006232436
Jul 2006141722
Aug 2006112930
Sep 2006184231
Oct 200693020
Nov 2006262933
Dec 2006798
Jan 2007211119
Feb 200762719
Mar 2007112016
Apr 200795845
May 200787162
Jun 200773222
Jul 2007114424
Aug 200732023
Sep 200743217
Oct 200783027
Nov 2007123023
Dec 2007103033
Jan 200893221
Feb 2008112618
Mar 2008164852
Apr 2008272131
May 2008273026
Jun 2008112424
Jul 2008274345
Aug 2008343925
Sep 2008364327
Oct 2008352519
Nov 2008212413
Dec 20087198
Jan 2009212616
Feb 200915239
Mar 2009622837
Apr 2009201419
May 200982311
Jun 2009102412
Jul 2009153110
Aug 2009302219
Sep 2009181720
Oct 2009482050
Nov 2009342832
Dec 2009401116
Jan 2010971511
Feb 201031104
Mar 2010202419
Apr 2010204120
May 2010261910
Jun 2010191917
Jul 2010253120
Aug 201029169
Sep 2010171512
Oct 2010102011
Nov 2010102218
Dec 2010241916
Jan 2011142119
Feb 201191819
Mar 2011162419
Apr 201172622
May 2011124524
Jun 20117135
Jul 2011181621
Aug 2011132125
Sep 2011121917
Oct 2011132115
Nov 2011232216
Dec 2011131913
Jan 2012282423
Feb 2012141917
Mar 2012162018
Apr 2012131917
May 2012162614
Jun 20129613
Jul 2012101018
Aug 2012221623
Sep 2012101415
Oct 2012292018
Nov 20121697
Dec 2012141012
Jan 2013292219
Feb 201322721
Mar 201312922
Apr 2013231720
May 2013132117
Jun 2013221214
Jul 2013101625
Aug 201331411
Sep 20132487
Oct 2013141310
Nov 201312154
Dec 201314136
Jan 2014201522
Feb 20141088
Mar 2014131520
Apr 201414511
May 2014777
Jun 201417108
Jul 201414126
Aug 20141746
Sep 20143129
Oct 201423721
Nov 20142185
Dec 201427792
Jan 2015341221
Feb 2015211016
Mar 2015231522
Apr 201516325
May 2015271721
Jun 201521128
Jul 2015271021
Aug 2015301716
Sep 20151748
Oct 2015151512
Nov 20151266
Dec 20152967
Jan 2016301013
Feb 201636816
Mar 2016201622
Apr 2016281313
May 2016261519
Jun 2016231217
Jul 2016262229
Aug 2016201919
Sep 2016131720
Oct 2016112810
Nov 201632215
Dec 201612614
Jan 201701818
Feb 201712622
Mar 201732326
Apr 20174918
May 201712510
Jun 20172248
Jul 201722720
Aug 201743914
Sep 20172327
Oct 201762513
Nov 20173226
Dec 201753048
Jan 2018025518
Feb 2018820111
Mar 201811587
Apr 201811279
May 201838315
Jun 201875410
Jul 201814510
Aug 20182566
Sep 20180519
Oct 201845814
Nov 20184649
Dec 201856126
Jan 20197584
Feb 20197425
Mar 20192932
Apr 20193063
May 201934108
Jun 20192053
Jul 201929410
Aug 20193417
Sep 20192411
Oct 201934129
Nov 20195223
Dec 20191887
Jan 20201631
Feb 20201811
Mar 20201522
Apr 20201564
May 20205032
Jun 20201825
Jul 20203331
Aug 2020854
Sep 2020810
Oct 20203233
Nov 20202331
Dec 20203820
Jan 202128104
Feb 202134118
Mar 20212353
Apr 20212824

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 69 (4)
Molecular Pharmacology
Vol. 69, Issue 4
1 Apr 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleOriginal Article

The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor

Tetyana Milojević, Veronika Reiterer, Eduard Stefan, Vladimir M. Korkhov, Mario M. Dorostkar, Eszter Ducza, Egon Ogris, Stefan Boehm, Michael Freissmuth and Christian Nanoff
Molecular Pharmacology April 1, 2006, 69 (4) 1083-1094; DOI: https://doi.org/10.1124/mol.105.015818

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleOriginal Article

The Ubiquitin-Specific Protease Usp4 Regulates the Cell Surface Level of the A2a Receptor

Tetyana Milojević, Veronika Reiterer, Eduard Stefan, Vladimir M. Korkhov, Mario M. Dorostkar, Eszter Ducza, Egon Ogris, Stefan Boehm, Michael Freissmuth and Christian Nanoff
Molecular Pharmacology April 1, 2006, 69 (4) 1083-1094; DOI: https://doi.org/10.1124/mol.105.015818
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
  • A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics